Gain Therapeutics GANX
NASDAQ GANX
$1.18 -0.01 (-0.84%)
As of: Oct 21, 2026 · 1:26 PM EDT

Gain Therapeutics (GANX) Receivables - Net (2020 - 2021)

Updated

Gain Therapeutics (GANX) reported Receivables - Net of $24,713 for Q3 2021, down 93.0% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Receivables - Net (2020 - 2021) Analysis & Trends

At the end of FY2020, Gain Therapeutics posted Receivables - Net of $8,548.

  • Five-year quarterly Receivables - Net spans a low of $4,486 in Q1 2021 and a high of $353,166 in Q2 2021.
  • Per Business Quant data, the three quarters before Q3 2021 came in at $353,166 (Q2 2021), $4,486 (Q1 2021) and $8,548 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn
10 Gain Therapeutics 49.94 Mn -9.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 24,713.00
Jun 30, 2021 353,166.00
Mar 31, 2021 4,486.00
Dec 31, 2020 8,548.00
API Access

Gain Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=GANX&period=max&api_key=YOUR_API_KEY